Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Investcafe
$23.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

FAS Clears Farmstandart OAO To Buy Lekko-PRIME


Tuesday, 11 Sep 2012 02:30am EDT 

PRIME reported that Russia’s Federal Antimonopoly Service (FAS) has cleared pharmaceutical producer Farmstandart OAO (Pharmstandard) to acquire pharma producer Lekko. Lekko, located in the Vladimir Region, focuses on the research, development, production, and promotion of high-end medication. The company produces 11 brands of pharmaceuticals, amounting to more than 50 million packs annually. The acquisition of Lekko is expected to enlarge Pharmstandard’s portfolio of prescription medicines, a Pharmstandard representative said earlier without providing the value of the deal. 

Latest Key Developments in Pharmaceuticals

Company Quote

1259.2
13.9 +1.12%
11 Jul 2014